JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB131546

Anti-NFkB p105 / p50 抗体

Anti-NFkB p105 / p50 antibody

Be the first to review this product! Submit a review

|

(14 Publications)

Rabbit Polyclonal NFkB p105 / p50 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 14 publications. Immunogen corresponding to Synthetic Peptide within Human NFKB1 aa 900 to C-terminus conjugated to Keyhole Limpet Haemocyanin.

別名を表示する

Nuclear factor NF-kappa-B p105 subunit, DNA-binding factor KBF1, EBP-1, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, NFKB1

2 Images
Immunocytochemistry/ Immunofluorescence - Anti-NFkB p105 / p50 antibody (AB131546)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-NFkB p105 / p50 antibody (AB131546)

Immunofluorescent analysis of methanol-fixed HeLa cells labelling NFkB p105 / p50 with ab131546 at 1/100 dilution.

Western blot - Anti-NFkB p105 / p50 antibody (AB131546)
  • WB

Unknown

Western blot - Anti-NFkB p105 / p50 antibody (AB131546)

All lanes:

Western blot - Anti-NFkB p105 / p50 antibody (ab131546) at 1/500 dilution

Lane 1:

HeLa cell extract

Lane 2:

HeLa cell extract with blocking peptide

Predicted band size: 105 kDa

false

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

ICC/IF, WB

applications

免疫原

Synthetic Peptide within Human NFKB1 aa 900 to C-terminus conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.

P19838

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/200", "ICCIF-species-notes": "<p></p>" } } }

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
バッファー組成
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.88% Sodium chloride
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
-20°C
保管に関する情報
Stable for 12 months at -20°C

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105.. Nuclear factor NF-kappa-B p105 subunit. P105 is the precursor of the active p50 subunit (Nuclear factor NF-kappa-B p50 subunit) of the nuclear factor NF-kappa-B (PubMed : 1423592). Acts as a cytoplasmic retention of attached NF-kappa-B proteins by p105 (PubMed : 1423592).. Nuclear factor NF-kappa-B p50 subunit. Constitutes the active form, which associates with RELA/p65 to form the NF-kappa-B p65-p50 complex to form a transcription factor (PubMed : 1740106, PubMed : 7830764). Together with RELA/p65, binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions (PubMed : 1740106, PubMed : 7830764).
See full target information NFKB1

文献 (14)

Recent publications for all applications. Explore the full list and refine your search

iScience 27:109048 PubMed38464592

2024

Specific knockout of macrophage SHP2 promotes macrophage M2 polarization and alleviates renal ischemia-reperfusion injury.

Applications

Unspecified application

Species

Unspecified reactive species

Meilian Du,Shanbao Zhang,Xiaoyu Wang,Chen Liu,Linrong Pan,Xiao Chen,Yinghui Qi

Nature cell biology 23:1314-1328 PubMed34876692

2021

A single-cell transcriptomic landscape of the lungs of patients with COVID-19.

Applications

Unspecified application

Species

Unspecified reactive species

Si Wang,Xiaohong Yao,Shuai Ma,Yifang Ping,Yanling Fan,Shuhui Sun,Zhicheng He,Yu Shi,Liang Sun,Shiqi Xiao,Moshi Song,Jun Cai,Jiaming Li,Rui Tang,Liyun Zhao,Chaofu Wang,Qiaoran Wang,Lei Zhao,Huifang Hu,Xindong Liu,Guoqiang Sun,Lu Chen,Guoqing Pan,Huaiyong Chen,Qingrui Li,Peipei Zhang,Yuanyuan Xu,Huyi Feng,Guo-Guang Zhao,Tianzi Wen,Yungui Yang,Xuequan Huang,Wei Li,Zhenhua Liu,Hongmei Wang,Haibo Wu,Baoyang Hu,Yong Ren,Qi Zhou,Jing Qu,Weiqi Zhang,Guang-Hui Liu,Xiu-Wu Bian

PLoS neglected tropical diseases 15:e0009339 PubMed33857149

2021

Orientia tsutsugamushi modulates cellular levels of NF-κB inhibitor p105.

Applications

Unspecified application

Species

Unspecified reactive species

Tanaporn Wangsanut,Katelynn R Brann,Haley E Adcox,Jason A Carlyon

Oncology reports 45: PubMed33760159

2021

MicroRNA‑129 inhibits colorectal cancer cell proliferation, invasion and epithelial‑to‑mesenchymal transition by targeting SOX4.

Applications

Unspecified application

Species

Unspecified reactive species

Zhiping Chen,Tianyu Zhong,Jinghua Zhong,Yang Tang,Baodian Ling,Lanfeng Wang

Frontiers in genetics 11:563265 PubMed33574830

2021

Downregulated microRNA-129-5p by Long Non-coding RNA NEAT1 Upregulates PEG3 Expression to Aggravate Non-alcoholic Steatohepatitis.

Applications

Unspecified application

Species

Unspecified reactive species

Zhi Zhang,Huiqing Wen,Bangjian Peng,Jun Weng,Fanhong Zeng

Journal of diabetes research 2020:7019597 PubMed33123597

2020

Regulation and Mechanism of miR-518d through the PPAR-Mediated NF-B Pathway in the Development of Gestational Diabetes Mellitus.

Applications

Unspecified application

Species

Unspecified reactive species

Hui Qiu,Xuemin Liu,Shenshen Yao,Jiaren Zhou,Xue Zhang,Juan Du

Experimental and therapeutic medicine 20:2279-2283 PubMed32765705

2020

Effects of lentinan on NF-κB activity in the liver of burn rats with sepsis.

Applications

Unspecified application

Species

Unspecified reactive species

Qianwen Lv,Yunpeng Gu,Yue Qi,Zhenjun Liu,Gui-E Ma

Experimental and therapeutic medicine 20:2090-2098 PubMed32782521

2020

Pterostilbene reduces endothelial cell apoptosis by regulation of the Nrf2-mediated TLR-4/MyD88/NF-κB pathway in a rat model of atherosclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaowei Xiong,Weihang Lu,Kaihua Zhang,Weimin Zhou

Experimental and therapeutic medicine 20:1541-1549 PubMed32742385

2020

Mechanism of TGF-β1 inhibiting Kupffer cell immune responses in cholestatic cirrhosis.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Qian,Yuwen Jiao,Guangyao Wang,Hanyang Liu,Xiang Cao,Haojun Yang

Experimental physiology 105:793-808 PubMed32086850

2020

Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Li Fan,Hai Li,Weihua Wang
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com